Managing secondary fungal infections in severe COVID-19: how to move forward?

Verweij, Paul E; van de Veerdonk, Frank L

Verweij, Paul E; van de Veerdonk, Frank L.

Verweij PE; Department of Medical Microbiology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands; Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands. Electronic address: paul.verweij@radboudumc.nl.
van de Veerdonk FL; Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands; Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands.

Lancet Respir Med ; 10(2): 127-128, 2022 02.

Article in English | MEDLINE | ID: covidwho-1751528

Subject(s)

COVID-19; Coinfection; Mycoses; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coinfection / COVID-19 / Mycoses Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google